Cargando…
Label-Free Quantification of Anti-TNF-α in Patients Treated with Adalimumab Using an Optical Biosensor
This study describes the development of an immunosensory label-free quantification methodology based on surface plasmon resonance (SPR) and its applicability in measuring/evaluating therapeutic drug monitoring (TDM) of anti-TNF-α monoclonal antibody (adalimumab) in rheumatoid arthritis (RA) patients...
Autores principales: | Bustos, Rosa Helena, Zapata, Carlos, Esteban, Efraín, García, Julio-César, Jáuregui, Edwin, Jaimes, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876701/ https://www.ncbi.nlm.nih.gov/pubmed/29495408 http://dx.doi.org/10.3390/s18030691 |
Ejemplares similares
-
Optical Biosensors for Therapeutic Drug Monitoring
por: Garzón, Vivian, et al.
Publicado: (2019) -
Label-Free Optical Resonator-Based Biosensors
por: Rho, Donggee, et al.
Publicado: (2020) -
Label-Free MicroRNA Optical Biosensors
por: Lai, Meimei, et al.
Publicado: (2019) -
Optical Biosensors for Label-Free Detection of Small Molecules
por: Peltomaa, Riikka, et al.
Publicado: (2018) -
Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
por: Zamora-Atenza, Carlos, et al.
Publicado: (2014)